$43,288 交易量
Jan 21, 2026
尼波利单抗 / 红斑狼疮
是
Halda Therapeutics / Haida Therapeutics
是
Darzalex Faspro
No
Ottava
Yes
Vaccine
No
Procedure
Yes
Europe
Yes
Carvykti
Yes
Rybrevant
Yes
Trufill
No
Administration
Yes
China
Yes
$43,288 交易量
尼波利单抗 / 红斑狼疮
$339 交易量
是
Halda Therapeutics / Haida Therapeutics
$4,472 交易量
是
Darzalex Faspro
$266 交易量
No
Ottava
$7,631 交易量
Yes
Vaccine
$7,002 交易量
No
Procedure
$665 交易量
Yes
Europe
$568 交易量
Yes
Carvykti
$355 交易量
Yes
Rybrevant
$2,497 交易量
Yes
Trufill
$2,551 交易量
No
Administration
$16,687 交易量
Yes
China
$254 交易量
Yes
This market will resolve based on the next earnings announcement of Johnson & Johnson currently scheduled to take place on January 21, 2026 at 8:30 AM EST.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.This market will resolve based on the next earnings announcement of Johnson & Johnson currently scheduled to take place on January 21, 2026 at 8:30 AM EST.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
市场开放时间: Jan 12, 2026, 12:39 PM ET
交易量
$43,288结束日期
Jan 21, 2026市场开放时间
Jan 12, 2026, 12:39 PM ETResolver
0x65070BE91...已提议结果: Yes
无争议
最终结果: Yes

警惕外部链接哦。
警惕外部链接哦。
Frequently Asked Questions